93 related articles for article (PubMed ID: 24300751)
21. Nizatidine for the treatment of patients with quetiapine-induced weight gain.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Kilic N
Hum Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 14716710
[TBL] [Abstract][Full Text] [Related]
22. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
[TBL] [Abstract][Full Text] [Related]
23. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
24. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
Di Francesco V; Sacco T; Zamboni M; Bissoli L; Zoico E; Mazzali G; Minniti A; Salanitri T; Cancelli F; Bosello O
Ann Nutr Metab; 2007; 51(1):75-81. PubMed ID: 17356258
[TBL] [Abstract][Full Text] [Related]
25. The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.
Porter JA; Raebel MA; Conner DA; Lanty FA; Vogel EA; Gay EC; Merenich JA
Am J Manag Care; 2004 Jun; 10(6):369-76. PubMed ID: 15209480
[TBL] [Abstract][Full Text] [Related]
26. Croatian experience with sibutramine in the treatment of obesity--multicenter prospective study.
Stimac D; Ruzić A; Majanović SK
Coll Antropol; 2004 Jun; 28(1):215-21. PubMed ID: 15636078
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive α-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics: a double-blind randomized placebo-controlled study.
Kim NW; Song YM; Kim E; Cho HS; Cheon KA; Kim SJ; Park JY
Int Clin Psychopharmacol; 2016 Sep; 31(5):265-74. PubMed ID: 27276401
[TBL] [Abstract][Full Text] [Related]
28. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
Wang TF; Pei D; Li JC; Tsai WC; Tsai CC; Yao CY; Chang ET; Hsieh MC; Su KY; Kuo SW
Int J Clin Pract; 2005 Jul; 59(7):746-50. PubMed ID: 15963197
[TBL] [Abstract][Full Text] [Related]
29. Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment.
Borovicka MC; Fuller MA; Konicki PE; White JC; Steele VM; Jaskiw GE
J Clin Psychiatry; 2002 Apr; 63(4):345-8. PubMed ID: 12000209
[TBL] [Abstract][Full Text] [Related]
30. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
Daniels SR; Long B; Crow S; Styne D; Sothern M; Vargas-Rodriguez I; Harris L; Walch J; Jasinsky O; Cwik K; Hewkin A; Blakesley V;
Pediatrics; 2007 Jul; 120(1):e147-57. PubMed ID: 17576783
[TBL] [Abstract][Full Text] [Related]
32. Orlistat and sibutramine beyond weight loss.
Mannucci E; Dicembrini I; Rotella F; Rotella CM
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
[TBL] [Abstract][Full Text] [Related]
33. Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Sood A; Ebbert JO; Clark MM; Croghan IT; Schroeder DR; Hays JT
Nicotine Tob Res; 2009 Dec; 11(12):1479-84. PubMed ID: 19884116
[TBL] [Abstract][Full Text] [Related]
34. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
Aronne LJ; Halseth AE; Burns CM; Miller S; Shen LZ
Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
[TBL] [Abstract][Full Text] [Related]
35. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.
Kim SH; Lee YM; Jee SH; Nam CM
Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682
[TBL] [Abstract][Full Text] [Related]
36. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.
Barkeling B; Elfhag K; Rooth P; Rössner S
Int J Obes Relat Metab Disord; 2003 Jun; 27(6):693-700. PubMed ID: 12833113
[TBL] [Abstract][Full Text] [Related]
37. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
[TBL] [Abstract][Full Text] [Related]
38. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
Hauner H; Meier M; Wendland G; Kurscheid T; Lauterbach K; ;
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial.
Torp-Pedersen C; Caterson I; Coutinho W; Finer N; Van Gaal L; Maggioni A; Sharma A; Brisco W; Deaton R; Shepherd G; James P;
Eur Heart J; 2007 Dec; 28(23):2915-23. PubMed ID: 17595194
[TBL] [Abstract][Full Text] [Related]
40. Phentermine, sibutramine and metformin could be used for the prevention and treatment of steroid-induced weight gain.
Alisky JM
Med Hypotheses; 2007; 68(2):460-1. PubMed ID: 17008024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
